Abstract: An intracranial pressure measurement device has a first plate abutting a patient's dura mater and displaced from a second plate abutting an endocranial surface of the patient's skull. The displacement of the first plate and second plate during elevated intracranial pressures are indicated visually on the device and visible through, e.g., X-ray imaging. This allows the intracranial pressure to be correlated to the mechanical displacement of the first plate from the second plate.

Abstract: An intracranial pressure measurement device has a first plate abutting a patient's dura mater and displaced from a second plate abutting an endocranial surface of the patient's skull. The displacement of the first plate and second plate during elevated intracranial pressures are indicated visually on the device and visible through, e.g., X-ray imaging. This allows the intracranial pressure to be correlated to the mechanical displacement of the first plate from the second plate.

Abstract: An intracranial pressure measurement device has a first plate abutting a patient's dura mater and displaced from a second plate abutting an endocranial surface of the patient's skull. The displacement of the first plate and second plate during elevated intracranial pressures are indicated visually on the device and visible through, e.g., X-ray imaging. This allows the intracranial pressure to be correlated to the mechanical displacement of the first plate from the second plate.

Abstract: A device may receive Internet of Things (IoT) data generated by a plurality of different IoT devices, and may group the IoT data into groups of data packages at configured time intervals or in response to events. The device may generate data notifications for the groups of data packages, and may provide the data notifications to a blockchain node, associated with the device and included in a network of blockchain nodes associated with data consumer devices, to cause the data notifications to be securely provided to corresponding ones of the data consumer devices. The device may receive, from one of the data consumer devices, a request for a data package of the groups, and may authenticate the one of the data consumer devices. The device may provide the data package to the one of the data consumer devices when authenticated.

Abstract: A car tissue box holder is provided. The tissue box is secured to the sun visor of the vehicle by hook and loop or Velcro straps. A pair of straps securing a metal plate to the tissue box attaches to a magnet holder plate secured to the sun visor. The magnet holder plate has a magnetic component help by a plastic component of the magnet holder plate. The Velcro straps are thread through the respective plates. The plates allow adjustment to different sized of tissue box and sizes of sun visors and easy or removal of the tissue box.

Abstract: A user equipment may determine a latency requirement of the user equipment, and may determine a first set of latencies between the user equipment and a first multi-access edge computing (MEC) device. The user equipment may determine a second set of latencies between the user equipment and a second MEC device, and may calculate a first violation probability based on the latency requirement and the first set of latencies. The user equipment may calculate a second violation probability based on the latency requirement and the second set of latencies, and may identify the first MEC device or the second MEC device based on the first violation probability and the second violation probability. The user equipment may selectively initiate a MEC handoff of the user equipment to the first MEC device or the second MEC device based on identifying the first MEC device or the second MEC device.

Abstract: A device may receive Internet of Things (IoT) data generated by a plurality of different IoT devices, and may group the IoT data into groups of data packages at configured time intervals or in response to events. The device may generate data notifications for the groups of data packages, and may provide the data notifications to a blockchain node, associated with the device and included in a network of blockchain nodes associated with data consumer devices, to cause the data notifications to be securely provided to corresponding ones of the data consumer devices. The device may receive, from one of the data consumer devices, a request for a data package of the groups, and may authenticate the one of the data consumer devices. The device may provide the data package to the one of the data consumer devices when authenticated.

Abstract: A car tissue box holder is provided. The tissue box is secured to the sun visor of the vehicle by hook and loop or Velcro straps. A pair of straps securing a metal plate to the tissue box attaches to a magnet holder plate secured to the sun visor. The magnet holder plate has a magnetic component help by a plastic component of the magnet holder plate. The Velcro straps are thread through the respective plates. The plates allow adjustment to different sized of tissue box and sizes of sun visors and easy or removal of the tissue box.

Abstract: A user equipment may determine a latency requirement of the user equipment, and may determine a first set of latencies between the user equipment and a first multi-access edge computing (MEC) device. The user equipment may determine a second set of latencies between the user equipment and a second MEC device, and may calculate a first violation probability based on the latency requirement and the first set of latencies. The user equipment may calculate a second violation probability based on the latency requirement and the second set of latencies, and may identify the first MEC device or the second MEC device based on the first violation probability and the second violation probability. The user equipment may selectively initiate a MEC handoff of the user equipment to the first MEC device or the second MEC device based on identifying the first MEC device or the second MEC device.

Abstract: A user equipment may determine a latency requirement of the user equipment, and may determine a first set of latencies between the user equipment and a first multi-access edge computing (MEC) device. The user equipment may determine a second set of latencies between the user equipment and a second MEC device, and may calculate a first violation probability based on the latency requirement and the first set of latencies. The user equipment may calculate a second violation probability based on the latency requirement and the second set of latencies, and may identify the first MEC device or the second MEC device based on the first violation probability and the second violation probability. The user equipment may selectively initiate a MEC handoff of the user equipment to the first MEC device or the second MEC device based on identifying the first MEC device or the second MEC device.

Abstract: A user equipment may determine a latency requirement of the user equipment, and may determine a first set of latencies between the user equipment and a first multi-access edge computing (MEC) device. The user equipment may determine a second set of latencies between the user equipment and a second MEC device, and may calculate a first violation probability based on the latency requirement and the first set of latencies. The user equipment may calculate a second violation probability based on the latency requirement and the second set of latencies, and may identify the first MEC device or the second MEC device based on the first violation probability and the second violation probability. The user equipment may selectively initiate a MEC handoff of the user equipment to the first MEC device or the second MEC device based on identifying the first MEC device or the second MEC device.

Abstract: A method is provided for evaluating drug compounds based on their binding properties to human serum albumin wherein structural information at particular albumin binding regions is entered into a computer database and assessed with regard to particular contacting binding residues located in accordance with the invention. The information obtained through the computer database is thus useful in assessing and predicting drug interactions at albumin binding sites. Further, protein fragments including one or more albumin binding sites are provided which can be used in methods of assessing and designing drugs.

Abstract: A space division system (100) is disclosed, with the space division system (100) incorporating technology. The space division system (100) is disclosed as having a space divider (102) vertically suspended from a rail system (104). The rail system (104) includes a rail (106) with a pair of hanger clips (108) releasably secured to the rail (106) and capable of being moved along a continuum of the length of the rail (106). In one embodiment, the space divider (102) includes a main body (114) consisting of an opaque fabric. Associated with the main body (114) is lighting technology including a series of LED lights (116). Arrow lights (118) may be activated in an appropriate manner for emergency or other purposes. Color changing is also provided for purposes of wayfinding, signaling occupant activities or other external or internal circumstances.

Abstract: A high resolution structure of the hemalbumin binding complex is provided which includes the detailed atomic coordinates which reflect the binding site and the binding characteristics of the structure. This high resolution structure can be used in methods of determining the primary residues involved in gas binding, redox potential of iron, etc., and thus will be used to identify and optimize the gas binding characteristics of heme and albumin, so as to allow for the development of modified recombinant albumins containing heme and/or heme derivatives which have improved gas binding properties and which can be used for therapeutic purposes.

Abstract: A method is provided for evaluating drug compounds based on their binding properties to human serum albumin wherein structural information at particular albumin binding regions is entered into a computer database and assessed with regard to particular contacting binding residues located in accordance with the invention. The information obtained through the computer database is thus useful in assessing and predicting drug interactions at albumin binding sites. Further, protein fragments including one or more albumin binding sites are provided which can be used in methods of assessing and designing drugs.

Abstract: A space division system (100) is disclosed, with the space division system (100) incorporating technology. The space division system (100) is disclosed as having a space divider (102) vertically suspended from a rail system (104). The rail system (104) includes a rail (106) with a pair of hanger clips (108) releasably secured to the rail (106) and capable of being moved along a continuum of the length of the rail (106). In one embodiment, the space divider (102) includes a main body (114) consisting of an opaque fabric. Associated with the main body (114) is lighting technology including a series of LED lights (116). Arrow lights (118) may be activated in an appropriate manner for emergency or other purposes. Color changing is also provided for purposes of wayfinding, signaling occupant activities or other external or internal circumstances.

Abstract: A method is provided for increasing the safety and efficacy of albumin-binding drugs such as those used as anti-cancer, anti-infective, or anti-hypertensive drugs, or for numerous other conditions. In the preferred method, the invention modulates those drugs which bind at the IB site on human serum albumin by co-administering a compound which is highly tolerable to humans and which can bind competitively with those albumin-binding drugs at the IB binding site so as to increase the safety and efficacy of the drug. The invention is advantageous in that by administering the highly tolerable compound in a sufficient amount to compete with the targeted drug, the latter can be administered at a much lower dosage while maintaining or exceeding its potency. Compositions containing the combination of highly tolerable compound and albumin-bind drugs are also disclosed.

Abstract: A high resolution structure of the hemalbumin binding complex is provided which includes the detailed atomic coordinates which reflect the binding site and the binding characteristics of the structure. This high resolution structure can be used in methods of determining the primary residues involved in gas binding, redox potential of iron, etc., and thus will be used to identify and optimize the gas binding characteristics of heme and albumin, so as to allow for the development of modified recombinant albumins containing heme and/or heme derivatives which have improved gas binding properties and which can be used for therapeutic purposes.

Abstract: A set of ornamental beads and the method of making them. A bead can be customized by the use of an inner disk, which is made of plastic material and is about the size of a penny. Each inner disk has a through hole along its diameter. A customer selects whichever design, pattern, theme, pop culture items or logo, which is then applied to the face or faces of the disk, like stickers. The customization can take place over an E-commerce platform, where the customer can visualize various designs on screen, or in a store, where the sales clerk has a stock of such design stickers, ready to be applied to the inner disk. After the customer selects the requisite number of disks and their designs, if the beads are not already in stock, each of the disks is placed in a mold, which will be filled with liquid poly-gem material to form a bead-shaped object. The solidified poly-gem thus encases the inner disk to secure the design(s) on the inner disk within the bead-shaped poly-gem material.